58 min.


Recent data from two large randomized studies of segmentectomy for small (≤2cm) peripheral non-small cell lung cancer (NSCLC) treatment suggest a change is coming in the standard of care. In this STS webinar, an expert panel discusses how evolving robotic and imaging technologies are changing the landscape of treatment for early stage NSCLC. The session features a review of recent trials, advanced imaging, complex segmentectomy videos, and case scenarios. 


David C. Rice, MD
University of Texas MD Anderson Cancer Center
Houston, TX
Jason M. Long, MD, MPH
University of North Carolina
Chapel Hill, NC


Abbas E. Abbas, MD
Brown University
Providence, RI
Nasser K. Altorki, MD
Weill Cornell Medical College
New York, NY
Mark R. Dylewski, MD
Baptist Health/Miami Cancer Institute
Miami, FL
Kazuhiro Yasufuku, MD, PhD, FRCSC
University of Toronto 
Toronto, ON, Canada